Idioma:

Whole-of-population CRISPR point-of-care testing for congenital cytomegalovirus to prevent hearing and neurodevelopment disabilities through a public health approach

Sem texto completo

Citações Citado por

Título:
Whole-of-population CRISPR point-of-care testing for congenital cytomegalovirus to prevent hearing and neurodevelopment disabilities through a public health approach
Assuntos: Clinical Medicine and Science ; cytomegalovirus (cmv) infection ; population screening ; public health costs ; treatment
Notas: http://dx.doi.org/10.13039/501100000925
Descrição: A/Pr Valerie Sung | Congenital cytomegalovirus infection (cCMV) is the major infective cause of deafness and brain disability, both of which are potentially reversible with early treatment. Currently, there is no screening at birth, and cCMV is diagnosed too late for treatment. Our team will test and validate CRISPR, a new and cheap technology, on 110,000+ newborns to detect cCMV. This will revolutionise how cCMV is detected, make treatment more accessible and pave way to lower rates of deafness and cerebral palsy. | $2,058,921 | Clinical Trials and Cohort Studies Grants | Clinical Trials and Cohort Studies Grants
Data de criação/publicação: 2026
Idioma: Inglês

Links

Voltar para lista de resultados

Buscando em bases de dados remotas. Favor aguardar.